SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, ...
Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families. Through a ...
With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...
On Wednesday, Leerink Partners maintained their Outperform rating and $160.00 price target on shares of Illumina (NASDAQ:ILMN), coinciding with the launch of the company's new MiSeq i100 system. The ...
Bengaluru: Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs. New ...
How Illumina's Erin Imsand and her team helped develop reagents that can be stored at room temperature Originally published on Illumina News Center Illumina recently launched the MiSeq i100 and MiSeq ...
With room-temperature kit storage and shipping, Illumina's newest sequencers remove barriers to enable more insights and discoveries SAN DIEGO, Oct. 9, 2024 /PRNewswire/ -- Illumina, Inc. (ILMN), a ...
Illumina's Aneesh Natarajan takes us on the journey Originally published on Illumina News Center NORTHAMPTON, MA / ACCESS Newswire / January 22, 2025 / Illumina recently launched the MiSeq i100 and ...
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, unveiled its MiSeq i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback